trending Market Intelligence /marketintelligence/en/news-insights/trending/fernpolg0vxerb2gym0uhq2 content esgSubNav
In This List

Aquestive Therapeutics names chairman

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Aquestive Therapeutics names chairman

Warren, N.J.-based Aquestive Therapeutics Inc. said it appointed Santo Costa as the chairman of its board.

Costa joined the Aquestive board in 2015 and replaces Douglas Bratton, who will continue as a director of the specialty drug manufacturer. Costa has over four decades of experience in the pharmaceutical, healthcare and life sciences industries.

Costa is the former president, vice chairman and COO of Quintiles Transnational Corp. and oversaw all operating divisions and worldwide business development.